Key Highlights
- President Donald Trump is set to launch TrumpRx, a website offering lower-priced prescription drugs.
- The initiative uses “most favored nation” pricing agreements with major pharmaceutical companies.
- Pfizer will offer discounts of up to 50% on its drugs through the platform.
- Trump has been advocating for such policies since 2025, signing an executive order in March of that year.
The TrumpRx Launch: An Unlikely Comeback?
You might think this is new, but… it’s not. President Donald Trump has been trying to leverage his political capital post-presidency for years, and now he’s using old tricks in a new guise.
So, why now? Trump announced the launch of TrumpRx on February 5, 2026.
It’s designed to offer medications at lower prices, part of his administration’s effort to bring down drug costs. But the timing is suspiciously convenient for an ex-president who needs a platform to stay relevant.
The ‘Most Favored Nation’ Deal
And here’s how it works: The Trump administration secured deals with major pharmaceutical companies, including Pfizer, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Merck, Novartis, Novo Nordisk, and Sanofi. These deals involve selling drugs at prices that are no greater than those of comparable countries.
White House Press Secretary Karoline Leavitt urged people to tune in at 7 p.m., stating, “President Trump, Dr. Oz, and National Design Studio Director Joe Gebbia will be officially unveiling TrumpRx — a state-of-the-art website for Americans consumers to purchase low-cost prescription drugs.”
History of the Initiative
The roots of this project date back to 2025 when Trump announced more than a dozen deals with pharmaceutical industry giants. In each deal, the administration agreed to forego planned pharmaceutical industry tariffs in exchange for discounted medications sold directly to consumers via TrumpRx or Medicaid.
Pfizer’s Role
First to sign on was Pfizer, which said patients could buy its drugs at a 50% discount. They would offer the majority of their primary care treatments and some specialty brands. In his announcement, President Trump declared, “By taking this bold step, we’re ending the era of global price-gouging at the expense of American families and we’re making America healthy again.”
Controversies and Criticisms
Yet, there’s a catch. Critics argue that such deals could have unintended consequences. For instance, if TrumpRx becomes popular, it might undermine the market for other drugstores or insurance companies offering similar discounts.
Moreover, Trump’s push into this space comes at a time when his credibility is already questionable in many circles. The idea of a former president using his influence to launch such initiatives raises eyebrows and questions about his motives.
A Post-Presidential Presidency?
So, what does it all mean? It’s another example of how ex-presidents continue to seek relevance by leveraging their past achievements. TrumpRx might provide some relief for those struggling with drug costs, but its long-term impact remains uncertain. And as always in politics, the real story is often buried beneath layers of spin and rhetoric.